SynthesisPloS one2026

Hepatic arterial infusion chemotherapy (HAlC) versus sorafenib for hepatocellular carcinoma (HCC) in Barcelona Clinic Liver Cancer (BCLC) B/C: A systematic review and meta-analysis.

Zhengqiang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.